A novel CRIg‐targeted complement inhibitor protects cells from complement damage-Reference-Cited by-同舟云学术

A novel CRIg‐targeted complement inhibitor protects cells from complement damage

Published:2014-08-11 Issue:11 Volume:28 Page:4986-4999
ISSN:0892-6638
Container-title:The FASEB Journal
language:en
Short-container-title:FASEB j.

Author:

Qiao Qian¹²³,Teng Xiaoyan¹²³,Wang Na¹²³,Lu Renquan¹²³,Guo Lin¹²³,Zhang Xin¹²³,Du Yiqun¹²³,Wang Wenjuan⁴,Chen Suning⁴,Wu Qian⁴,He Guangsheng⁴,Wang Yingwei⁵,Hu Weiguo¹²³⁶

Affiliation:

1. Shanghai Cancer CenterShanghai Medical CollegeFudan UniversityShanghaiChina

2. Institutes of Biomedical SciencesShanghai Medical CollegeFudan UniversityShanghaiChina

3. Department of OncologyShanghai Medical CollegeFudan UniversityShanghaiChina

4. Ministry of Health Key Laboratory of Thrombosis and HematostasisJiangsu Institute of HematologyDepartment of HematologyFirst Affiliated Hospital of Soochow UniversitySuzhouChina

5. Department of Microbiology and ImmunologyNanjing Medical UniversityNanjingChina

6. Department of ImmunologyShanghai Medical CollegeFudan UniversityShanghaiChina

Funder

National Natural Science Foundation of China

Major State Basic Research Development Program of China

Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning

Publisher

Wiley

Subject

Genetics,Molecular Biology,Biochemistry,Biotechnology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1096/fj.14-258046

Reference49 articles.

1. Complement-targeted therapeutics

2. Complement: a key system for immune surveillance and homeostasis

3. Novel analogues of the therapeutic complement inhibitor compstatin with significantly improved affinity and potency

4. The alternative complement pathway revisited

5. Structure of C3b reveals conformational changes that underlie complement activity

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CG001, a C3b-targeted complement inhibitor, blocks 3 complement pathways: development and preclinical evaluation;Blood Advances;2024-08-02

2. Reciprocal Interaction with Neutrophils Facilitates Cutaneous Accumulation of Liposomes;ACS Nano;2024-07-01

3. The human factor H protein family – an update;Frontiers in Immunology;2024-02-12

4. The biology of VSIG4: Implications for the treatment of immune-mediated inflammatory diseases and cancer;Cancer Letters;2023-01

5. V-Set and immunoglobulin domain containing (VSIG) proteins as emerging immune checkpoint targets for cancer immunotherapy;Frontiers in Immunology;2022-09-15